Abstract
ETS proteins (such as PU.1, Fli-1 and ETS-1) have been shown to play important roles in normal and abnormal hematopoiesis. We examined the expression of the ELF subfamily of ETS genes (ELF-1, MEF and NERF) in acute myeloid leukemia (AML) cells using Northern blot analysis. ELF-1 and MEF were expressed in all samples, whereas NERF was not. The relative expression (RE) of MEF, but not ELF-1, was significantly lower (P<0.0001) in AML with t(8;21) and t(15;17) compared with AML with normal karyotype. The pattern of MEF expression was not uniform among cells with CD34(+)/CD33(+). It is suggested that the low RE of MEF might be part of a gene expression profile characterizing AML with a good prognosis.
MeSH terms
-
Acute Disease
-
Adult
-
Aged
-
Biomarkers, Tumor / analysis*
-
Biomarkers, Tumor / biosynthesis
-
Biomarkers, Tumor / genetics
-
Chromosomes, Human, Pair 15 / ultrastructure
-
Chromosomes, Human, Pair 17 / ultrastructure
-
Chromosomes, Human, Pair 21 / ultrastructure
-
Chromosomes, Human, Pair 8 / ultrastructure
-
DNA-Binding Proteins / analysis*
-
DNA-Binding Proteins / biosynthesis
-
DNA-Binding Proteins / genetics
-
Female
-
Gene Expression Regulation, Leukemic
-
Hematopoietic Stem Cells / chemistry
-
Humans
-
Karyotyping
-
Leukemia, Myeloid / classification
-
Leukemia, Myeloid / genetics
-
Leukemia, Myeloid / metabolism*
-
Male
-
Middle Aged
-
Prognosis
-
RNA, Messenger / analysis
-
RNA, Messenger / biosynthesis
-
RNA, Neoplasm / analysis
-
RNA, Neoplasm / biosynthesis
-
Transcription Factors / analysis*
-
Transcription Factors / biosynthesis
-
Transcription Factors / genetics
-
Translocation, Genetic
Substances
-
Biomarkers, Tumor
-
DNA-Binding Proteins
-
ELF4 protein, human
-
RNA, Messenger
-
RNA, Neoplasm
-
Transcription Factors
-
ELF2 protein, human